Cargando…
The improved cure fraction for esophageal cancer in Linzhou city
BACKGROUND: Survival of esophageal cancer in Linzhou was seen to increase over the past few decades and is higher than the average level of China due to the implementation of comprehensive prevention and control measures. In population-based studies, relative survival is a common index to approximat...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171140/ https://www.ncbi.nlm.nih.gov/pubmed/30285671 http://dx.doi.org/10.1186/s12885-018-4867-7 |
_version_ | 1783360734255644672 |
---|---|
author | Liu, Shuzheng Guo, Lanwei Chen, Qiong Yu, Liang Li, Bianyun Cao, Xiaoqin Sun, Xibin |
author_facet | Liu, Shuzheng Guo, Lanwei Chen, Qiong Yu, Liang Li, Bianyun Cao, Xiaoqin Sun, Xibin |
author_sort | Liu, Shuzheng |
collection | PubMed |
description | BACKGROUND: Survival of esophageal cancer in Linzhou was seen to increase over the past few decades and is higher than the average level of China due to the implementation of comprehensive prevention and control measures. In population-based studies, relative survival is a common index to approximate disease-specific survival. However, the cure fraction maybe great interest to patients and physicians. This study aimed to investigate the cure fraction of esophageal cancer in Linzou city during 2003–2012 with a cure model. METHODS: We carried out a population-based study of 8067 esophageal cancer patients in the Linzhou city during 2003–2012. Flexible parametric cure models were used to estimate cure proportions and median survival times of uncured by year of diagnosed and age. In each model, an interaction between calendar year and age were included. All variables in the model were included both as constant and time-varying effects. RESULTS: The 5-year relative survival rate was increased in every age group from 2003 to 2012. The huge increase in the cure proportion was observed in each age group. At the year of 2011–2012, 79.8%, 58.0%, 123.4% and 162.7% improvements of cure proportion were seen in age group 19–49, 50–59, 60–69 and 70–99 years compared with year of 2003–2004. Meanwhile, survival of ‘uncured’ patients changed little in all age group. CONCLUSIONS: The improvement of survival in Linzhou city during 2003–2012 was mainly due to an increasing cure proportion. Huge improvement of cure fraction within short period is likely due to the organized screening of esophageal cancer in Linzhou city. |
format | Online Article Text |
id | pubmed-6171140 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61711402018-10-10 The improved cure fraction for esophageal cancer in Linzhou city Liu, Shuzheng Guo, Lanwei Chen, Qiong Yu, Liang Li, Bianyun Cao, Xiaoqin Sun, Xibin BMC Cancer Research Article BACKGROUND: Survival of esophageal cancer in Linzhou was seen to increase over the past few decades and is higher than the average level of China due to the implementation of comprehensive prevention and control measures. In population-based studies, relative survival is a common index to approximate disease-specific survival. However, the cure fraction maybe great interest to patients and physicians. This study aimed to investigate the cure fraction of esophageal cancer in Linzou city during 2003–2012 with a cure model. METHODS: We carried out a population-based study of 8067 esophageal cancer patients in the Linzhou city during 2003–2012. Flexible parametric cure models were used to estimate cure proportions and median survival times of uncured by year of diagnosed and age. In each model, an interaction between calendar year and age were included. All variables in the model were included both as constant and time-varying effects. RESULTS: The 5-year relative survival rate was increased in every age group from 2003 to 2012. The huge increase in the cure proportion was observed in each age group. At the year of 2011–2012, 79.8%, 58.0%, 123.4% and 162.7% improvements of cure proportion were seen in age group 19–49, 50–59, 60–69 and 70–99 years compared with year of 2003–2004. Meanwhile, survival of ‘uncured’ patients changed little in all age group. CONCLUSIONS: The improvement of survival in Linzhou city during 2003–2012 was mainly due to an increasing cure proportion. Huge improvement of cure fraction within short period is likely due to the organized screening of esophageal cancer in Linzhou city. BioMed Central 2018-10-03 /pmc/articles/PMC6171140/ /pubmed/30285671 http://dx.doi.org/10.1186/s12885-018-4867-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Liu, Shuzheng Guo, Lanwei Chen, Qiong Yu, Liang Li, Bianyun Cao, Xiaoqin Sun, Xibin The improved cure fraction for esophageal cancer in Linzhou city |
title | The improved cure fraction for esophageal cancer in Linzhou city |
title_full | The improved cure fraction for esophageal cancer in Linzhou city |
title_fullStr | The improved cure fraction for esophageal cancer in Linzhou city |
title_full_unstemmed | The improved cure fraction for esophageal cancer in Linzhou city |
title_short | The improved cure fraction for esophageal cancer in Linzhou city |
title_sort | improved cure fraction for esophageal cancer in linzhou city |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171140/ https://www.ncbi.nlm.nih.gov/pubmed/30285671 http://dx.doi.org/10.1186/s12885-018-4867-7 |
work_keys_str_mv | AT liushuzheng theimprovedcurefractionforesophagealcancerinlinzhoucity AT guolanwei theimprovedcurefractionforesophagealcancerinlinzhoucity AT chenqiong theimprovedcurefractionforesophagealcancerinlinzhoucity AT yuliang theimprovedcurefractionforesophagealcancerinlinzhoucity AT libianyun theimprovedcurefractionforesophagealcancerinlinzhoucity AT caoxiaoqin theimprovedcurefractionforesophagealcancerinlinzhoucity AT sunxibin theimprovedcurefractionforesophagealcancerinlinzhoucity AT liushuzheng improvedcurefractionforesophagealcancerinlinzhoucity AT guolanwei improvedcurefractionforesophagealcancerinlinzhoucity AT chenqiong improvedcurefractionforesophagealcancerinlinzhoucity AT yuliang improvedcurefractionforesophagealcancerinlinzhoucity AT libianyun improvedcurefractionforesophagealcancerinlinzhoucity AT caoxiaoqin improvedcurefractionforesophagealcancerinlinzhoucity AT sunxibin improvedcurefractionforesophagealcancerinlinzhoucity |